[The modern view on the use of aspirin for the primary prophylaxis of cardiovascular diseases in women].
Cardiovascular diseases (CVD) occupy the first place in the world among all causes of disability and death. Aspirin is an effective antithrombocyte agent, the efficiency and safety of which has been demonstrated by numerous studies. Despite its high effectiveness in treatment of acute myocardial infarction and secondary prophylaxis of CVD both in men and women, the use of aspirin for primary prophylaxis is still questionable. Presently, the appropriateness of aspirin application as a means of primary prevention of CVD in women older than 45 has not been clarified yet. The present article discusses this question.
Zakharov
O V
OV
Arablinskiĭ
A V
AV
D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011322:Primary Prevention / Q000639:trends*; D016387:Women's Health
D005343:Fibrinolytic Agents; D001241:Aspirin